VBI hepatitis B vaccine meets main goals in late-stage trial

VBI Vaccines Inc said on Monday a late-stage study testing its hepatitis B vaccine met its main goals.



from Reuters: Health News https://reut.rs/2WR69oD
http://bit.ly/2zwRqiM

June 17, 2019 | Labels: , |

This entry was posted on June 17, 2019 and is filed under health , Reuters: Health News . You can follow any responses to this entry through the RSS 2.0 feed. or trackback from your own site.